Meta-analysis of the efficacy and safety of daratumumab in the treatment of multiple myeloma

doi:10.12998/wjcc.v11.i29.7091

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2442)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1321

Figures (1-4)

291

Tables (1-1)

208

Sum=1889

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

129

Download

345

Sum=474

Oct 16, 2023 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Cases. Oct 16, 2023; 11(29): 7091-7100
Published online Oct 16, 2023. doi: 10.12998/wjcc.v11.i29.7091

Full Size Figure Download Figure

Figure 4 Funnel plot of the incidence of adverse event. A: Thrombocytopenia; B: Neutropenia.

Citation: Wang P, Jin SY. Meta-analysis of the efficacy and safety of daratumumab in the treatment of multiple myeloma. World J Clin Cases 2023; 11(29): 7091-7100
URL: https://www.wjgnet.com/2307-8960/full/v11/i29/7091.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i29.7091